Lpath Inc (NASDAQ:LPTN)

Add to Watch List

Set Alert

4.92 Data as of 1:05pm ET	+0.02 / +0.41% Today’s Change	4.13 Today\|\|\|52-Week Range 7.01	-2.57% Year-to-Date

4.92

Data as of 1:05pm ET

+0.02 / +0.41%

Today’s Change

4.13

Today|||52-Week Range

7.01

-2.57%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$64.3M

Company Description

Lpath, Inc. is a biotechnology company focused on the discovery and development of lipidomic-based therapeutic antibodies, a field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. Its product candidates are currently in clinical development, and pre-clinical evaluation. The iSONEP is the ocular formulation of sonepcizumab, a humanized monoclonal antibody against sphingosine-1-phosphate and the Sphingomab is the original mouse version of this monoclonal antibody. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA.

Contact Information

Lpath, Inc.

4025 Sorrento Valley Boulevard

San Diego California 92121

P:(858) 678-0800

Investor Relations:

www.lpath.com

Employees

Shareholders

Individual stakeholders	6.86%
Mutual fund holders	6.15%
Other institutional	14.22%

Top Executives

Scott R. Pancoast, MBA	President, Chief Executive Officer & Director
Gary J. G. Atkinson, CPA	Chief Financial Officer, Secretary & Senior VP
Gary Woodnutt, PhD	Senior Vice President-Research
Dario A. Paggiarino, MD	Chief Development Officer & Senior Vice President
Roger Allen Sabbadini, PhD	Vice President

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.